News Summary
The New York Office of Cannabis Management (OCM) is moving to revoke the business permits of Omnium Health due to severe regulatory violations. Investigations found that the company had engaged in a ‘rent-a-license scheme,’ renting space to unlicensed entities and distributing unauthorized cannabis products. The OCM has proposed significant penalties, including a $1 million fine and a recall of all products linked to unlicensed processes. This action may lead to broader compliance scrutiny across New York’s cannabis industry.
New York – The New York Office of Cannabis Management (OCM) has initiated steps to revoke the business permits of Omnium Health, a cannabis processor based in Long Island. This action follows an investigation launched in February 2025, which uncovered significant regulatory violations by the company, including renting space to unlicensed entities and distributing their products through its legitimate dispensary networks.
The OCM has characterized Omnium’s practices as a “rent-a-license scheme,” which constitutes a serious breach of regulations designed to maintain fairness within the cannabis market. Acting Executive Director Felicia Reid emphasized that cannabis licenses are non-transferable and that only licensed entities are allowed to produce and distribute cannabis products.
As part of its enforcement actions, the OCM has submitted a notice to an administrative law judge, seeking the revocation of both Omnium’s processing and distribution licenses. The proposed penalties are severe, including a minimum civil fine of $1 million for the sale of unauthorized cannabis products, a recall of all items produced by unlicensed processors, and mandated destruction of those products. It is projected that the recall could involve millions of cannabis goods, however, the specific details of the products affected will only be disclosed once Omnium responds with the necessary information.
Regulatory officials overseeing the case have made it clear that Omnium’s situation is indicative of broader compliance issues within the industry. The OCM has stated that further investigations into other companies potentially violating industry regulations are already in progress, proving that this crackdown on Omnium may just be the initial step in a much more extensive enforcement campaign. The OCM officials have underscored the importance of compliance and accountability within the cannabis sector.
Omnium Health has been a prominent player in the cannabis industry, processing products for well-known brands including California’s STIIIZY and Mfused. However, in light of complaints regarding the unauthorized renting of its license, Omnium had previously issued a stop work order and quarantined many of its products. This proactive response represents an attempt by the company to mitigate damage ahead of regulatory findings.
Should Omnium contest the administrative charges, there could be additional penalties dependent on the total value of the unlicensed products sold. Meanwhile, some industry leaders have expressed support for the OCM’s enforcement actions, recognizing the necessity for stricter oversight. However, there are also concerns regarding broader issues surrounding compliance, particularly a practice known as “inversion,” where licensed businesses may be utilizing illegal out-of-state marijuana.
This latest situation follows previous regulatory actions, including a notice against Lexachrom Analytical Laboratory seeking penalties of $2 million for non-compliance with state cannabis laws. As the OCM intensifies its regulatory efforts, the outcomes of the investigations into Omnium Health and other companies will provide critical insights into the operational integrity of New York’s cannabis markets and the effectiveness of state-level regulatory measures.
The potential ramifications of this crackdown on Omnium Health could resonate throughout New York’s cannabis sector, fostering a climate of compliance among licensed operators while also highlighting an ongoing struggle with systemic challenges. The future implications for the industry will become more apparent as the regulatory outlook evolves and additional details regarding Omnium’s case surface.
Deeper Dive: News & Info About This Topic
HERE Resources
Charges Filed Against Omnium Health for Illegal Cannabis Operations
New York Regulators Target Omnium Health for Illicit Cannabis Sales
New York Penalizes Omnium Health Over Cannabis Violations
Additional Resources
- Crain’s New York: Omnium Canna Faces Millions in Fines
- Crain’s New York: Mayoral Candidates on Key Business Issues
- Fox News: NYC Business Exodus Predictions
- Wikipedia: Cannabis in New York
- New York Times: Steven Fulop’s Partnership for NYC
- Encyclopedia Britannica: Financial Operations
Author: STAFF HERE NEW YORK WRITER
The NEW YORK STAFF WRITER represents the experienced team at HERENewYork.com, your go-to source for actionable local news and information in New York, the five boroughs, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as New York Fashion Week, Macy's Thanksgiving Day Parade, and Tribeca Film Festival. Our coverage extends to key organizations like the Greater New York Chamber of Commerce and United Way of New York, plus leading businesses in finance and media that power the local economy such as JPMorgan Chase, Goldman Sachs, and Bloomberg. As part of the broader HERE network, including HEREBuffalo.com, we provide comprehensive, credible insights into New York's dynamic landscape.
